Pura Vida Investments’s Pfizer PFE Stock Holding History

Pura Vida Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-300,000	Closed	-$11.7M	–	318
2021 Q2	$11.7M	Buy	+300,000	New	+$11.7M	0.37%	64

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pura Vida Investments's PFE Position: Q4 2022 in Review

Pura Vida Investments sold out of Pfizer (PFE) in Q4 2022, closing a stake of 50,000 shares — an estimated $2.4M sold.

Pura Vida Investments first reported a position in PFE in Q2 2015 and held it in 7 quarters. The position peaked at $8.99M in Q4 2021. 3,266 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

Pura Vida Investments reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
Pura Vida Investments sold 50,000 Pfizer shares in Q4 2022, an estimated $2.4M.
Pura Vida Investments first reported a position in Pfizer in Q2 2015 and held it in 7 quarters.
Pura Vida Investments's Pfizer position peaked at $8.99M in Q4 2021.
3,266 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.